XAIR News and Press, Beyond Air Inc. From 02/14/22

BioDelivery Sciences International BDSI +51% Collegium Pharmaceutical to acquire BioDelivery Sciences for $5.60/share in all cash deal. Cornerstone Building Brands (NYSE:CNR) +22% CD&R makes non-binding proposal to acquire cornerstone building brands. Splunk SPLK +9%&#...

Beyond Air, Inc. (XAIR) Q3 2022 Earnings Conference Call February 10, 2022 4:30 PM ET Company Participants Maria Yonkoski - Head of Investor Relations Steve Lisi - Chairman and Chief Executive Officer Douglas Larson - Chief Financial Officer Duncan Fatkin - Chief Commercial Officer Conference...

The following slide deck was published by Beyond Air, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Beyond Air, Inc. 2022 Q3 - Results - Earnings Call Presentation

Beyond Air press release (NASDAQ:XAIR): Q3 GAAP EPS of -$0.29 misses by $0.03. Revenue of $0M. For further details see: Beyond Air GAAP EPS of -$0.29 misses by $0.03, revenue of $0M

LungFit ® PH premarket approval (PMA) submission under active review by U.S. FDA; approval and commercial launch anticipated in the first half of calendar year 2022 along with European CE Mark Raised $30 million for oncology affiliate Beyond Cancer™, Beyond Air mai...

GARDEN CITY, N.Y., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections an...

GARDEN CITY, N.Y., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections an...

Beyond Air CEO Steven Lisi recently bought the dip in XAIR stock, increasing his stake by ~4%. I see no attempt in Mr. Lisi's actions to artificially pump the stock to sell his stake at a higher price - I explain why. I believe that the recent decline in XAIR's share price, which ...

In a regulatory filing, Beyond Air (NASDAQ:XAIR) disclosed that its CEO Steven Lisi bought 40K shares of common stock at $8.53 for a total outlay of $341K on December 10th, boosting his stake by about 4%. The move leaves Steven Lisi with ownership of 1.17M shares For fur...

Gainers: Inspira Technologies (NASDAQ:IINN) +92%. Ensysce Biosciences (NASDAQ:ENSC) +79%. Insignia (NASDAQ:ISIG) +44%. Hovnanian Enterprises (NASDAQ:HOVNP) +33%. American Virtual Cloud Technologies (NASDAQ:AVCT) +31%. Blue Star Foods Corp. (NASDAQ:BSFC) +16%. Hovnanian (NYSE:HO...